For relevance BD1 has 5 quarters of cash left we all know how fast medi companies burn cash on R and D and their ROE (return on equity) is almost negative permanently (9/10 years) ditto their earnings; ZNO does not need to answer the question of cash quarters because it is cash flow positive every quarter. Further their ROE fy '20 was near +80%. I'll stay the course with the profitable one thanks.
For relevance BD1 has 5 quarters of cash left we all know how...
Add ZNO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.89M | |||
| Open | High | Low | Value | Volume |
| 2.7¢ | 2.8¢ | 2.7¢ | $1.486K | 54.53K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 54147 | 2.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.9¢ | 208000 | 3 |
View Market Depth
| Last trade - 14.52pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
2.8¢ |
Change
0.000 ( 3.70 %) |
||||
| Open | High | Low | Volume | ||
| 2.8¢ | 2.8¢ | 2.8¢ | 26875 | ||
| Last updated 14.52pm 14/06/2024 ? | |||||
| ZNO (ASX) Chart |